EDP Sciences logo
Search
Menu
All issues Volume 38 / No 1 (January-February 2007) Vet. Res., 38 1 (2007) 25-36 References
Open Access
Issue
Vet. Res.
Volume 38, Number 1, January-February 2007
Page(s) 25 - 36
DOI https://doi.org/10.1051/vetres:2006042
Published online 01 November 2006
How to cite this article Vet. Res. (2007) 25-36
References of  Vet. Res. 38 (2007) 25-36
  1. Amiri P., Locksley R.M., Parslow T.G., Sadick M., Rector E., Ritter D., McKerrow J.H., Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice, Nature (1992) 356:604-607 [CrossRef] [PubMed].
  2. Andrade Z.A., Cheever A.W., Characterization of the murine model of schistosomal hepatic periportal fibrosis, Int. J. Exp. Pathol. (1993) 74:195-202 [PubMed].
  3. Bogdan C., Nathan C., Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10, Ann. NY Acad. Sci. (1993) 685:713-739.
  4. Bogh H.O., Willingham A.L., Johansen M.V., Eriksen L., Christensen N.O., Recovery of Schistosoma japonicum from experimentally infected pigs by perfusion of liver and mesenteric veins, Acta Vet. Scand. (1997) 38:147-155 [PubMed].
  5. Cheever A.W., Xu Y., Sher A., Finkelman F.D., Cox T.M., Macedonia J.G., Schistosoma japonicum-infected mice show reduced hepatic fibrosis and eosinophilia and selective inhibition of interleukin-5 secretion by CD4+ cells after treatment with anti-interleukin-2 antibodies, Infect. Immun. (1993) 61:1288-1292 [PubMed].
  6. Cheever A.W., Finkelman F.D., Cox T.M., Anti-interleukin-4 treatment diminishes secretion of Th2 cytokines and inhibits hepatic fibrosis in murine schistosomiasis Japonica, Parasite Immunol. (1995) 17:103-109 [PubMed].
  7. Cheever A.W., Yap G.S., Immunologic basis of disease and disease regulation in schistosomiasis, Chem. Immunol. (1997) 66:159-176 [PubMed].
  8. Chen M.G., Schistosoma japonicum and S. japonicum-like infections - Epidemiology, clinical and pathological aspects, in: Jordan P., Webbe G., Sturrock R.F. (Eds.), Human schistosomiasis, CAB International, Oxon, 1993, pp. 242-243.
  9. Chensue S.W., Terebuh P.D., Warmington K.S., Hershey S.D., Evanoff H.L., Kunkel S.L., Higashi G.I., Role of IL-4 and IFN-gamma in Schistosoma mansoni egg-induced hypersensitivity granuloma formation. Orchestration, relative contribution, and relationship to macrophage function, J. Immunol. (1992) 148:900-906 [PubMed].
  10. Darwich L., Pié S., Rovira A., Segalés J., Domingo M., Oswald I.P., Mateu E., Cytokine mRNA expression profiles in lymphoid tissues of pigs naturally affected by postweaning multisystemic wasting syndrome, J. Gen. Virol. (2003) 84:2117-2125 [CrossRef] [PubMed].
  11. Davies S., Grogan J., Blank R., Lim K., Locksley R., McKerrow J., Modulation of blood fluke development in the liver by hepatic CD4+ lymphocytes, Science (2001) 294:1358-1361 [CrossRef].
  12. Doetze A., Satoguina J., Burchard G., Rau T., Loliger C., Fleischer B., Hoerauf A., Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift, Int. Immunol. (2000) 12:623-630 [CrossRef] [PubMed].
  13. Fallon P.G., Immunopathology of schistosomiasis: a cautionary tale of mice and men, Immunol. Today (2000) 21:29-35 [CrossRef] [PubMed].
  14. Fallon P.G., Richardson E.J., McKenzie G.J., McKenzie A.N., Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent, J. Immunol. (2000) 164:2585-2591 [PubMed].
  15. Grogan J.L., Kremsner P.G., Deelder A.M., Yazdanbakhsh M., Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection, J. Infect. Dis. (1998) 177:1433-1437 [PubMed].
  16. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., Roncarolo M.G., A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature (1997) 389:737-742 [CrossRef] [PubMed].
  17. Hurst M.H., Shi Y.E., Lindberg R., Pathology and course of natural Schistosoma japonicum infection in pigs: results of a field study in Hubei province, China, Ann. Trop. Med. Parasitol. (2000) 94:461-477 [PubMed].
  18. Iburg T., Balemba O.B., Danizer V., Leifsson P.S., Johansen M.V., Pathogenesis of congenital infection with Schistosoma japonicum in pigs, J. Parasitol. (2002) 88:1021-1024 [PubMed].
  19. Jaattela M., Biologic activities and mechanisms of action of tumor necrosis factor-alpha/ cachectin, Lab. Invest. (1991) 64:724-742 [PubMed].
  20. Johansen M.V., Effect of praziquantel treatment on experimental porcine Schistosoma japonicum infection, Parasitology (1998) 116:519-524 [CrossRef] [PubMed].
  21. Johansen M.V., Bogh H.O., Nansen P., Christensen N.O., Schistosoma japonicum infection in the pig as a model for human schistosomiasis Japonica, Acta Trop. (2000) 76:85-99 [CrossRef] [PubMed].
  22. Johansen M.V., Iburg T., Bogh H.O., Christensen N.O., Postnatal challenge infections of congenitally Schistosoma japonicum-infected piglets, J. Parasitol. (2001) 87:813-815 [PubMed].
  23. Johansen M.V., Ørnbjerg N., Prenatal Schistosoma japonicum infection in piglets: effect of repeated exposure of the dams on treatment efficacy and susceptibility to challenge infections, J. Parasitol. (2004) 90:392-396 [CrossRef] [PubMed].
  24. Kaplan M., Whitfield J., Boros D., Grusby M., Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response, J. Immunol. (1998) 160:1850-1856 [PubMed].
  25. Karanja D.M., Hightower A.W., Colley D.G., Mwinzi P.N., Galil K., Andove J., Secor W.E., Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study, Lancet (2002) 360:592-596 [CrossRef] [PubMed].
  26. King C.L., Medhat A., Malhotra I., Nafeh M., Helmy A., Khaudary J., Ibrahim S., El Sherbiny M., Zaky S., Stupi R.J., Brustoski K., Shehata M., Shata T., Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity, J. Immunol. (1996) 156:4715-4721 [PubMed].
  27. King C., Dickman K., Tisch D., Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis, Lancet (2005) 365:1561-1569 [CrossRef] [PubMed].
  28. Letterio J.L., Roberts A.B., TGF-b: a critical modulator of immune cell function, Clin. Immunol. Immunopathol. (1997) 84:244-250 [CrossRef] [PubMed].
  29. McManus D.P., Ross A.G., Sleigh A.C., Williams G.M., Yang W., Li Y.S., Li Y., Acosta L., Waine G.J., Production of interleukin-10 by peripheral blood mononuclear cells from residents of a marshland area in China endemic for Schistosoma japonicum, Parasitol. Int. (1999) 48:169-177 [CrossRef] [PubMed].
  30. Medhat A., Shehata M., Bucci K., Mohamed S., Dief A.D., Badary S., Galal H., Nafeh M., King C.L., Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment, J. Infect. Dis. (1998) 178:512-519 [PubMed].
  31. Moloney N.A., Webbe G., A rapid method for the infection of laboratory mice with Schistosoma japonicum, Trans. R. Soc. Trop. Med. Hyg. (1982) 76:200-203 [CrossRef] [PubMed].
  32. Montenegro S.M., Miranda P., Mahanty S., Abath F.G., Teixeira K.M., Coutinho E.M., Brinkman J., Goncalves I., Domingues L.A., Domingues A.L., Sher A., Wynn T.A., Cytokine production in acute versus chronic human schistosomiasis mansoni: the cross-regulatory role of interferon-gamma and interleukin-10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens, J. Infect. Dis. (1999) 179:1502-1514 [CrossRef] [PubMed].
  33. Mwatha J.K., Kimani G., Kamau T., Mbugua G.G., Ouma J.H., Mumo J., Fulford A.J., Jones F.M., Butterworth A.E., Roberts M.B., Dunne D.W., High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni, J. Immunol. (1998) 160:1992-1999 [PubMed].
  34. Oswald I.P., Dozois C.M., Barlagne R., Fournout S., Johansen M.V., Bogh H.O., Cytokine mRNA expression in pigs infected with Schistosoma japonicum, Parasitology (2001) 122:299-307 [CrossRef] [PubMed].
  35. Pié S., Lallès J.P., Blazy F., Laffitte J., Sève B., Oswald I.P., Weaning is associated with an up-regulation of expression of inflammatory cytokines in the intestine of piglets, J. Nutr. (2004) 134:641-647 [PubMed].
  36. Punnonen J., Malefyt de Waal R., van Vlasselaer P., Gauchat J.F., de Vries J.E., IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes, J. Immunol. (1993) 151:1280-1209 [PubMed].
  37. Ross A., Sleigh A., Li Y., Davis G., Williams G., Jiang Z., Feng Z., McManus D., Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st Century, Clin. Microbiol. Rev. (2001) 14:270-295 [CrossRef] [PubMed].
  38. Rumbley C.A., Zekavat S.A., Sugaya H., Perrin P.J., Ramadan M.A., Phillips S.M., The schistosome granuloma: characterization of lymphocyte migration, activation, and cytokine production, J. Immunol. (1998) 161:4129-4137 [PubMed].
  39. Rumbley C.A., Sugaya H., Zekavat S.A., El Refaei M., Perrin P.J., Phillips S.M., Activated eosinophils are the major Source of Th2-associated cytokines in the schistosome granuloma, J. Immunol. (1999) 162:1003-1009 [PubMed].
  40. Stadecker M.J., The regulatory role of the antigen-presenting cell in the development of hepatic immunopathology during infection with Schistosoma mansoni, Pathobiology (1999) 67:269-272 [CrossRef] [PubMed].
  41. Techau M.E., Johansen M.V., Lind P., Ornbjerg N., The effect of colostrum on pigs pre-natally or post-natally exposed to Schistosoma japonicum, Parasitology (2004) 129:597-604 [CrossRef] [PubMed].
  42. Vennervald B., Dunne D., Morbidity in schistosomiasis: an update, Curr. Opin. Infect. Dis. (2004) 5:439-447 [CrossRef].
  43. Weiner H.L., Oral tolerance: immune mechanisms and treatment of autoimmune diseases, Immunol. Today (1997) 18:335-343 [CrossRef] [PubMed].
  44. Willingham A.L., Bogh H.O., Vennervald B.J., Johansen M.V., Eriksen L., Christensen N.O., Nansen P., Worm establishment and egg production of Schistosoma japonicum in pigs infected by percutaneous methods or intramuscular injection, Vet. Parasitol. (1996) 61:157-163 [PubMed].
  45. Willingham A.L., Johansen M.V., Bogh H.O., Ito A., Andreassen J., Lindberg R., Christensen N.O., Nansen P., Congenital transmission of Schistosoma japonicum in pigs, Am. J. Trop. Med. Hyg. (1999) 60:311-312 [PubMed].
  46. Wynn T.A., IL-13 effector functions, Annu. Rev. Immunol. (2003) 21:425-456 [PubMed].
  47. Wynn T.A., Thompson R.W., Cheever A.W., Mentink-Kane M.M., Immunopathogenesis of schistosomiasis, Immunol. Rev. (2004) 201:156-167 [PubMed].
  48. Zhang Z., Wu H., Chen S., Hu L., Xie Z., Qiu Y., Su C., Cao J.P., Wu Y., Zhang S., Wu G., Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum, Trans. R. Soc. Trop. Med. Hyg. (1997) 91:606-608 [CrossRef] [PubMed].
  49. Zhou Y., Lin G., Baarsch M.J., Scamurra R.W., Murtaugh M.P., Interleukin-4 suppresses inflammatory cytokine gene transcription in porcine macrophages, J. Leukoc. Biol. (1994) 56:507-513 [PubMed].
  50. Zuany-Amorim C., Creminon C., Nevers M.C., Nahori M.A., Vargaftig B.B., Pretolani M., Modulation by IL-10 of antigen-induced IL-5 generation, and CD4+ T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity, J. Immunol. (1996) 157:377-384 [PubMed].